Bank Julius Baer & Co. Ltd Zurich Sells 17,938 Shares of GE HealthCare Technologies Inc. $GEHC

Bank Julius Baer & Co. Ltd Zurich lessened its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 25.1% in the fourth quarter, Holdings Channel reports. The institutional investor owned 53,530 shares of the company’s stock after selling 17,938 shares during the period. Bank Julius Baer & Co. Ltd Zurich’s holdings in GE HealthCare Technologies were worth $4,454,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its holdings in shares of GE HealthCare Technologies by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock worth $4,287,658,000 after purchasing an additional 267,058 shares in the last quarter. Dodge & Cox increased its holdings in shares of GE HealthCare Technologies by 16.8% in the 3rd quarter. Dodge & Cox now owns 27,517,311 shares of the company’s stock worth $2,066,550,000 after purchasing an additional 3,949,361 shares in the last quarter. Capital Research Global Investors increased its holdings in shares of GE HealthCare Technologies by 25.0% in the 3rd quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock worth $1,875,400,000 after purchasing an additional 4,998,154 shares in the last quarter. Hotchkis & Wiley Capital Management LLC increased its holdings in shares of GE HealthCare Technologies by 17.1% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 8,432,374 shares of the company’s stock worth $633,271,000 after purchasing an additional 1,232,828 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in shares of GE HealthCare Technologies by 8.9% in the 3rd quarter. Dimensional Fund Advisors LP now owns 5,362,717 shares of the company’s stock worth $402,647,000 after purchasing an additional 438,439 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on GEHC shares. JPMorgan Chase & Co. reduced their target price on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating for the company in a report on Thursday, April 30th. Evercore set a $80.00 target price on GE HealthCare Technologies in a report on Thursday, April 30th. Wells Fargo & Company reduced their target price on GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a report on Thursday, April 30th. Morgan Stanley lifted their target price on GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 4th. Finally, Stifel Nicolaus set a $80.00 target price on GE HealthCare Technologies in a report on Wednesday, April 29th. Eight research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of “Hold” and an average target price of $80.67.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $60.76 on Friday. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. GE HealthCare Technologies Inc. has a one year low of $58.75 and a one year high of $89.77. The firm has a market capitalization of $27.64 billion, a P/E ratio of 14.54, a PEG ratio of 1.41 and a beta of 0.74. The business has a fifty day moving average of $69.58 and a 200 day moving average of $76.73.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The firm had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. During the same period in the previous year, the firm earned $1.01 EPS. The business’s revenue was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

Insider Buying and Selling

In other news, Director Watkin Phoebe L. Yang acquired 1,000 shares of the business’s stock in a transaction that occurred on Friday, May 8th. The stock was bought at an average price of $63.01 per share, with a total value of $63,010.00. Following the completion of the acquisition, the director directly owned 13,702 shares of the company’s stock, valued at approximately $863,363.02. The trade was a 7.87% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Peter J. Arduini acquired 4,169 shares of the business’s stock in a transaction that occurred on Thursday, April 30th. The stock was purchased at an average cost of $59.92 per share, with a total value of $249,806.48. Following the acquisition, the chief executive officer directly owned 259,424 shares of the company’s stock, valued at $15,544,686.08. This trade represents a 1.63% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased a total of 11,847 shares of company stock valued at $719,555 over the last ninety days. 0.36% of the stock is owned by insiders.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.